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Although cases of lymphoplasmacytic sclerosing pancreatitis (LSP) associated with idiopathic retroperitoneal ﬁbrosis have been
reported,theassociationisrare.Wedescribea74-year-oldmanwhopresentedwithobstructivejaundiceandweightloss.Nineteen
months earlier, he had been diagnosed with idiopathic retroperitoneal ﬁbrosis and treated with bilateral ureteric stents. Initial in-
vestigationsweresuggestiveofadiagnosisofLSP,however,amalignantcausecouldnotberuledout.Heunderwentanexploratory
laparotomy and frozen sections conﬁrmed the diagnosis of LSP. An internal biliary bypass was performed using a Roux loop of
jejunum, and the patient made an uneventful recovery. This case illustrates the diﬃculty in distinguishing LSP from pancreatic
carcinoma preoperatively.
Copyright © 2008 Nigel K. F. Koo Ng et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Lymphoplasmacytic sclerosing pancreatitis (LSP) or autoim-
mune pancreatitis is a rare condition characterised by dif-
fuse ﬁbroinﬂammatory inﬁltrates that can involve both the
pancreatic ducts and acinar parenchyma. It is also known
as primary inﬂammatory sclerosis of the pancreas, scleros-
ing pancreatitis, autoimmune sclerosing pancreatitis, duct
destructive chronic pancreatitis, and sclerosing pancreatico-
cholangitis [1, 2].
Since the condition was ﬁrst described in 1961 by Sarles
et al., several cases have been reported, and in recent years,
LSP has become increasingly recognised as an important and
unique cause of chronic pancreatitis. Of particular note, it
presents with a pancreatic mass that can be extremely diﬃ-
culttodiﬀerentiatefrompancreaticcarcinoma(whichitmay
resemble both clinically and radiologically). It has been re-
ported that “benign but clinically suspicious” Whipple resec-
tions are relatively common in high-volume centers (9.2%)
and that LSP represents 23.4% of Whipple resections per-
formed for benign disease [3]. The occasional association
of LSP with other autoimmune conditions is well docu-
mented [4], including Sjogren’s syndrome, primary scleros-
ingcholangitis,inﬂammatoryboweldisease,andsystemiclu-
puserythematosus.AlthoughcasesofLSPassociatedwithid-
iopathic retroperitoneal ﬁbrosis have also been reported, the
association is rare. To our knowledge, not more than 14 cases
have been reported in the literature [4–11].
2. CASE REPORT
A 74-year-old Afro-Caribbean man presented with a 4-week
history of obstructive jaundice, weight loss, and fatigue. He
had a background of noninsulin-dependent diabetes and hy-
pertension. Nineteen months earlier, symptoms of polyuria
and nocturia had led to a diagnosis of retroperitoneal ﬁ-
brosis: renal function was impaired, and both kidneys were
poorly perfused on CT scan, with evidence of retroperi-
toneal ﬁbrosis obstructing both ureters. Subsequently, bilat-
eral ureteric stents were inserted.
Since then, the patient had been well until recently de-
veloping jaundice. USS showed extrahepatic and intrahep-
atic biliary dilatation but no gallstones. The pancreas was
bulky throughout, although no focal lesion was identiﬁed.2 HPB Surgery
ERCP showed an irregular stricture in the lower CBD sug-
gestive of malignancy (although the biliary brushings later
showed no malignant cells), and an endobiliary stent was
inserted. Segments of the pancreatic duct were also dilated.
CT conﬁrmed that the pancreas was markedly bulky with
no focal mass lesion or abnormal calciﬁcations. There was
thickening of soft tissue around the porta hepatis suggestive
of lymphadenopathy. Although the main concern was pan-
creatic carcinoma, LSP was also considered to be a possi-
ble diagnosis. An autoimmune screen was negative for ANA,
cytoplasmic antibodies (Hep-2), ANCA IIF, mitochondrial
antibodies, smooth muscle antibodies, liver/kidney micro-
somal antibodies, Anti-GPC, rheumatoid factor, and stri-
ated muscle antibodies. The IgG level was raised at 27.0g/L
(5.3–16.5g/L), particularly IgG4 at 15.10g/L (0.0–1.3g/L).
Although, there have been reports of an association with a
raised IgG4 level and LSP [12], the diagnosis in this case was
stillunclear.Toconﬁrmthediagnosis,anexploratorylaparo-
tomy was considered to be most appropriate (and preferable
t oE U SF N A )a si to ﬀered the opportunity to obtain multi-
ple biopsies from a diﬀusely enlarged pancreas, whilst also
oﬀering a therapeutic option.
Atlaparotomy,theentirepancreaswashard,swollen,and
actively inﬂamed, most particularly the body of the gland.
The appearances were not typical for pancreatic cancer or
chronic pancreatitis. A shave biopsy of a nodule on the body
of pancreas plus three core biopsies with a Trucut needle
and a fourth from the head of pancreas were submitted to
frozen-sectionhistopathologyexamination;allshowedﬂorid
chronic inﬂammation but no cancer. A portion of thickened
retroperitoneumtissueinfrontoftheaortawasalsoremoved
and this was shown to be benign ﬁbrotic tissue. Since the
pathology was consistent with a diagnosis of LSP, an internal
biliary bypass was performed using a Roux loop of jejunum.
The patient made a good postoperative recovery and was re-
ferred to gastroenterology for further management. Steroids
were given postoperatively and he was discharged nine days
later.
3. DISCUSSION
LSP primarily aﬀects middle-aged men, with a mean age
of 56 years [13]. There is a male predominance of approxi-
mately 2:1 [13]. The recently increasing number of articles
on LSP is an indication of the current interest in this sub-
ject. Its similarity to pancreatic carcinoma, both clinically
and radiologically, presents a diagnostic challenge. In distin-
guishing LSP from pancreatic carcinoma, there are certain
suggestive features (see Table 1)[ 14–16]. The Japanese Pan-
creas Society proposed diagnostic criteria for LSP in 2002
(see Table 2)[ 14, 17].
Patients with LSP also have elevated serum IgG4 lev-
els which return to normal after administration of oral
steroids. Only a limited number of conditions are associated
with elevated IgG4 (such as atopic dermatitis, some para-
sitic diseases, pemphigus vulgaris, and pemphigus foliaceus).
Hamano and associates found high serum IgG4 concentra-
tions speciﬁcally in patients with LSP and not in those with
“ordinary” chronic pancreatitis, primary biliary cirrhosis,
Table 1: Diagnostic features suggestive of lymphoplasmacytic scle-
rosing pancreatitis.
Features suggestive of LSP
(1) Minimal or only mild symptoms, usually without
episodes of acute pancreatitis
(2)
Diﬀusely irregular narrowing of the main pancre-
atic duct and occasional stenosis of the intrapan-
creatic bile duct on ERCP images
(3) Diﬀuse enlargement of the pancreas
(4) Increased levels of serum gamma globulin or IgG
(5) Presence of autoantibodies
(6) Fibrotic changes with lymphocyte inﬁltration in
the pancreas
(7) Occasional association with other autoimmune
conditions
(8) Rare pancreatic calciﬁcation or cysts
(9) Clinical response to steroids
Table 2: To make a diagnosis of LSP, criteria a must be present,
together with criteria b and/or c.
Diagnostic criteria for LSP
(a)
Pancreatic imaging studies showing diﬀuse nar-
rowing of the main pancreatic duct with an irreg-
ular wall (more than 1/3 of the length of the entire
pancreas) with enlargement of the pancreas
(b) Abnormally elevated levels of serum gamma glob-
ulin and/or IgG, or the presence of autoantibodies
(c)
Histopathological examination of the pancreas
shows ﬁbrotic changes with lymphocyte and
plasma cell inﬁltration
primary sclerosing cholangitis, or Sjogren’s syndrome [12].
Not only does this ﬁnding suggest that LSP is immunolog-
ically diﬀerent, but it may also follow that IgG4 would be a
useful marker [12].
The association of LSP with other autoimmune condi-
tions, including retroperitoneal ﬁbrosis, is well recognised.
Our patient developed retroperitoneal ﬁbrosis prior to LSP,
but review of the 14 previous cases indicates that the on-
set of LSP is variable. Further, hydronephrosis secondary to
ureteric obstruction (as in our case) was not uncommon [4–
11]. The aetiology of retroperitoneal ﬁbrosis is unclear, but
the presence of autoantibodies and the response to steroids
in some patients may suggest an autoimmune mechanism.
Inﬁltration with IgG4-positive plasma cells has been shown
in both the pancreas and the retroperitoneal mass of patients
with LSP and retroperitoneal ﬁbrosis [5], indicating a likely
common aetiology.
LSP can be treated with medical therapy (steroids in re-
ducing dosage) or surgically. The prognosis is usually good
with either form of management but an important fac-
tor is the diﬃculty in diagnosing LSP, which can so often
mimic a malignant intra-abdominal mass. Preoperative orNigel K. F. Koo Ng et al. 3
even intraoperative diagnosis can be problematic, particu-
larly in patients for whom there are no clinical grounds to
suspect LSP. It has been suggested that surgical resection may
be an eﬀective treatment for LSP especially when immuno-
logical tests are normal or when malignancy is highly sus-
pected (this may be the only option to exclude malignancy)
[18]. However, surrounding inﬂammation can make surgical
resection hazardous, so a trial of steroids is worthwhile if a
conﬁdent diagnosis can be made without laparotomy [18].
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